Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
10/2012
10/04/2012WO2012135750A1 Combinations of akt inhibitor compounds and vemurafenib, and methods of use
10/04/2012WO2012135697A2 Novel rho kinase inhibitors and methods of use
10/04/2012WO2012135641A2 Aurora kinase inhibitors and methods of making and using thereof
10/04/2012WO2012135084A1 METABOLITES OF 2-(FURAN-2-YL)-7-(2-(4-(4-(2-METHOXYETHOXY)PHENYL)PIPERAZIN-1-YL)ETHYL)-7H-PYRAZOLO[4,3-e][1,2,4]TRIAZOLO[1,5-c]PYRIMIDIN-5-AMINE AND THEIR UTILITY AS ADENOSINE A2a RECEPTOR ANTAGONISTS
10/04/2012WO2012135083A1 METABOLITES OF 7-(2-(4-(6-FLUORO-3-METHYLBENZO[d]ISOXAZOL-5-YL)PIPERAZIN-1-YL)ETHYL)-2-(PROP-1-YNYL)-7H-PYRAZOLO[4,3-e][1,2,4]TRIAZOLO[1,5-c]PYRIMIDIN-5-AMINE AND THEIR UTILITY AS ADENOSINE A2a RECEPTOR ANTAGONISTS
10/04/2012WO2012135009A1 Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
10/04/2012WO2012130882A1 Fe(iii) complexes for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anaemias
10/04/2012WO2012130166A1 1-(arylmethyl)quinazoline-2,4(1h,3h)-diones as parp inhibitors and the use thereof
10/04/2012WO2012129792A1 Pyrimidinone compounds, preparation methods, pharmaceutical compositions and uses thereof
10/04/2012US20120253041 New phenylalanine derivatives
10/04/2012US20120252830 Substituted Aminobutyric Derivatives as Neprilysin Inhibitors
10/04/2012US20120252809 Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
10/04/2012US20120252790 Amino-Derivatives As Novel Inhibitors Of Histone Deacetylase
10/04/2012CA2844699A1 Combinations of akt inhibitor compounds and abiraterone, and methods of use
10/04/2012CA2831937A1 Combinations of akt inhibitor compounds and erlotinib, and methods of use
10/04/2012CA2831935A1 Combinations of akt inhibitor compounds and chemotherapeutic agents, and methods of use
10/04/2012CA2831932A1 Combinations of akt and mek inhibitor compounds, and methods of use
10/04/2012CA2831922A1 Combinations of akt inhibitor compounds and vemurafenib, and methods of use
10/04/2012CA2831015A1 1-(arylmethyl)quinazoline-2,4(1h,3h)-diones as parp inhibitors and the use thereof
10/04/2012CA2829240A1 Fe(iii) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias
10/03/2012EP2504319A1 Process for preparing a polymorph of the choline salt of a pyrimidin-5-yl acetic acid derivative
10/03/2012EP2504318A2 Crystalline salt forms of a pyrimidin-5-yl acetic acid derivative
10/03/2012EP2504314A1 Quinazoline derivatives
10/03/2012EP2504309A1 Synthesis of acetoxyacetaldehyde
10/03/2012CN102712602A Process for preparing 2-methyl-4-amino-5-cyanopyrimidine
10/03/2012CN102712587A Novel ethane diamine hepcidin antagonists
10/03/2012CN102712566A Synthesis of acetoxyacetaldehyde
10/03/2012CN102702116A 4-(3-chloro-4-methoxylanilino)-6-(3-amidophenyl)quinazoline compound or pharmaceutically-acceptable salt thereof and preparation methods and applications thereof
10/03/2012CN102702115A Synthetic method of 4-chloro-7-fluoro-6-nitro quinazoline
10/03/2012CN102702114A Method for preparing nitro orotic acid
10/03/2012CN102702113A 5-Fluorouracil derivative and preparation method and uses
10/03/2012CN102702112A Preparation method of bensulfuron
10/03/2012CN102702111A Processes for the preparation of 4-((4-((4-(2-cyanoethenyl)-2,6-dimethylphenyl)amino)-2-pyrimidinyl)amino)benzonitrile
10/03/2012CN102702110A Preparation method of 4-amino-5, 6-dichloropyrimidine
10/03/2012CN102698803A Ruthenium complex catalyst and preparation method and application thereof
10/03/2012CN101863844B Synthesis method of 6,7-substituted-4-aniline quinazoline
10/03/2012CN101801936B Metabolites and derivatives of ambrisentan
10/03/2012CN101759653B Preparation method of 6, 7-dimethoxy quinazoline-4-ketone
10/03/2012CN101687801B Ethers of naphtalene carboxylic acid amides as cancer cure
10/03/2012CN101654441B Anticoagulant compound, composition and application thereof
10/03/2012CN101460453B Novel sulfonamide compounds
10/02/2012US8278446 reacting 4-amino-6-chloro-pyrimidine-5-carbaldehyde with 4-benzyloxy-3-chloro-phenylamine in an aqueous solvent and a catalytic amount of hydrochloric acid, to providw 4-amino-6-(4-benzyloxy-3-chloro-phenylamino)-pyrimidine-5-carbaldehyde, then oximination with (2-morpholin-4-yl-ethyl)-hydroxylamine
10/02/2012US8278445 Preparation methods of azoxystrobin and its analogs
10/02/2012US8278357 Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators
10/02/2012US8278314 Quinazoline analogs as receptor tyrosine kinase inhibitors
10/02/2012US8278310 Amine salts of a CRTH2 antagonist
10/02/2012US8278309 Synthetic mimetics of host defense and uses thereof
10/02/2012US8278304 Substituted 4-hydroxypyrimidine-5-carboxamides
10/02/2012US8277599 Compounds for placing objects by self assembling and the use thereof
10/02/2012CA2575720C Pyrimidine derivatives
09/2012
09/27/2012WO2012129491A1 Trpv3 modulators
09/27/2012WO2012128965A2 Method for preparation of 5-substituted pyrimidines
09/27/2012US20120245351 Process for the preparation of lapatinib and its pharmaceutically acceptable salts
09/27/2012US20120245350 Methods for the preparation of lapatinib and the salts thereof
09/27/2012US20120245185 Aryl and heteroaryl sulfones as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
09/27/2012US20120245169 Certain chemical entities, compositions and methods
09/27/2012US20120245137 Aryl sulphone derivatives as calcium channel blockers
09/27/2012US20120245124 TRPV3 Modulators
09/27/2012US20120244119 Anti-infective agents and uses thereof
09/26/2012EP2501684A2 Process for the preparation of substituted phenylalanines
09/26/2012EP2501679A1 Heterocyclic antiviral compounds
09/26/2012EP2501233A1 Quinazoline compounds
09/26/2012CN102695700A Pyrimidine derivatives as protein tyrosine kinase 2 inhibitors
09/26/2012CN102695697A Novel multifunctional peptidase inhibitors, especially for medical use
09/26/2012CN102690238A Synthesis of barbituric acid derivative as RSK2 inhibitor and application thereof
09/26/2012CN102690237A Method for synthesizing high-purity azoxystrobin
09/26/2012CN102174025B Isotope labeling reagent as well as preparation method and application thereof
09/26/2012CN101808992B 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
09/26/2012CN101367767B Room temperature solvent-free synthesis of 3,4-dihydropyrimidine-2-ketone
09/26/2012CN101119965B Tetralin and indane derivatives and uses thereof
09/25/2012US8273897 Method for producing 2,2-difluoroethylamine derivative by amide hydrogenation
09/25/2012US8273879 Triazolo pyrimidine compounds
09/25/2012US8273878 Process for the preparation of pyrimidine compounds
09/25/2012US8273767 Bicyclic-substituted amines as histamine-3 receptor ligands
09/25/2012US8273758 Substituted tricyclic derivatives
09/25/2012US8273751 Organic compounds
09/25/2012US8273747 tert-Butyl (4-((4'-cyano-4-methoxy-biphenyl-3-ylmethyl)-amino)-cyclohexyl)-methyl-carbamate; hedgehog pathway agonists; alopecia; angiogenesis; wound healing; alzheimer's disease; inhibit aging effects on skin
09/25/2012CA2667285C New sulfonamide derivatives as bradykinin antagonists
09/20/2012WO2012125993A1 Solid state forms of rilpivirine base, and rilipivirine salts
09/20/2012WO2012125521A1 Quinazolinediones and their use
09/20/2012WO2012124696A1 Guanidine compound
09/20/2012WO2012123467A1 Pyrimidine amide compounds
09/20/2012WO2012122707A1 Quaternary ammonium salt compounds, preparation method, pharmaceutical composition and use thereof
09/20/2012US20120238578 Compositions useful as inhibitors of voltage-gated sodium channels
09/20/2012US20120238575 Antiproliferative pyrimidyl, fused pyrimidyl and pyrimidyl hydrazones
09/20/2012US20120238570 Inhibitors of the hedgehog pathway
09/20/2012CA2830157A1 Guanidine compound
09/20/2012CA2829123A1 Quinazolinediones and their use
09/19/2012EP2499118A2 Processes for the preparation of erlotinib hydrochloride form a and erlotinib hydrochloride form b
09/19/2012CN102686570A Mesoionic pesticides
09/19/2012CN102686569A Phenoxy-substituted pyrimidines as opioid receptor modulators
09/19/2012CN102675418A Luteinizing hormone-releasing hormone (LHRH) antagonist derivative, preparation method of LHRH antagonist derivative and application of LHRH antagonist derivative
09/19/2012CN102675315A Substitutive benzene alkyl contained purine compounds and preparation method and application thereof
09/19/2012CN102675226A 3-substituted-1-methyl-quinazoline-2,4-dione compounds, preparation method and application thereof
09/19/2012CN102675225A Synthesis method of erlotinib hydrochloride
09/19/2012CN102675224A 2-substituent-7-fluorine-4-aromatic mixed base quinazoline derivant and preparation method and use thereof
09/19/2012CN102675223A Preparation method for polysubstitution quinazoline and heterocyclic ring pyrimidine derivative
09/19/2012CN102675222A Method for preparing multi-substituted quinazoline and heterocyclic pyrimidine derivative
09/19/2012CN102675221A Intermediate in method for preparing pyrimidinedione derivative
09/19/2012CN102675220A Etravirine preparing method and intermediate of etravirine
1 ... 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 ... 427